1. Noyes FR, Mangine RE, Barber S. Early knee motion
after open and arthroscopic anterior cruciate
ligament reconstruction. Am J Sports Med. 1987;
15(2):149-60.
2. Noyes FR, Wojtys EM, Marshall MT. The early
diagnosis and treatment of developmental patella
infera syndrome. Clin Orthop Relat Res. 1991;
265(1):241-52.
3. Cetin M, Duran B, Demirkoprulu N, Guvenal T, Erden
O, Cetin A. Effects of diazeniumdiolates (NONOates)
and methylene blue on the reduction of postoperative
adhesion in rats. Gynecol Obstet Invest. 2004;
57(4):186-90.
4. Dinc S, Ozaslan C, Kuru B, Karaca S, Ustun H, Alagol
H, et al. Methylene blue prevents surgery-induced
peritoneal adhesions but impairs the early phase
of anastomotic wound healing. Can J Surg. 2006;
49(5):321-8.
5. Galili Y, Ben-Abraham R, Rabau M, Klausner J,
Kluger Y. Reduction of surgery-induced peritoneal
adhesions by methylene blue. Am J Surg. 1998;
175(1):30-2.
6. Heydrick SJ, Reed KL, Cohen PA, Aarons CB, Gower
AC, Becker JM, et al. Intraperitoneal administration of
methylene blue attenuates oxidative stress, increases
peritoneal fibrinolysis, and inhibits intraabdominal
adhesion formation. J Surg Res. 2007; 143(2):311-9.
7. Kluger Y, Weinbroum A, Ben-Avraham R, Galili Y,
Klausner J, Rabau M. Reduction in formation of
peritoneal adhesions by methylene blue in rats: a
dose response study. Eur J Surg. 2000; 166(7):568-71.
8. Yildiz H, Durmus AS, Simsek H, Yaman I. The
comparison of methylene blue and vitamin E in
prevention of abdominal postoperative adhesion
formation in rat uterine horn models: biochemical
and histopathologic evaluation. Acta Cir Bras. 2011;
26(1):51-7.
9. Farrokhi MR, Vasei M, Fareghbal S, Farrokhi N.
The effect of methylene blue on peridural fibrosis
formation after laminectomy in rats: an experimental
novel study. Spine J. 2011; 11(2):147-52.
10. Namazi H. Botulinum toxin as a novel addition to
anti-arthritis armamentarium: an experimental
study in rabbits. Int Immunopharmacol. 2006;
6(11):1743-7.
11. Namazi H, Torabi S. Novel use of botulinum toxin to
ameliorate arthrofibrosis: an experimental study in
rabbits. Toxicol Pathol. 2007; 35(5):715-8.
12. Seydi N, Dehghani S. Radiological study of the effect
of Platelet Rich Plasma (PRP) on experimentally
induced osteoarthritis in Guinea Pig’s stifle joint. J
Animal Poultry Sci. 2013; 2(3):73-8.
13. Toghraie FS, Chenari N, Gholipour MA, Faghih
Z, Torabinejad S, Dehghani S, et al. Treatment of
osteoarthritis with infrapatellar fat pad derived
mesenchymal stem cells in Rabbit. Knee. 2011;
18(2):71-5.
14. National Toxicology Program. Toxicology and
carcinogenesis studies of methylene blue trihydrate
(Cas No. 7220-79-3) in F344/N rats and B6C3F1
mice (gavage studies). Natl Toxicol Program Tech Rep
Ser. 2008; 540(1):1-224.
15. Luna LG. Manual of histologic staining methods of
the armed forces institute of pathology. 3rd ed. New
York: Blakiston Division, McGraw-Hill; 1968.
16. Aydin E, Uckan S, Ozdemir BH, Uyar P. Mitomycin
C effect on fibrous adhesions of rabbit
temporomandibular joint. Otolaryngol Head Neck
Surg. 2005; 133(5):672-6.
17. Brunelli G, Longinotti C, Bertazzo C, Pavesio A,
Pressato D. Adhesion reduction after knee surgery
in a rabbit model by hyaloglide®, a hyaluronan
derivative gel. J Orthop Res. 2005; 23(6):1377-82.
18. Emami MJ, Jaberi FM, Azarpira N, Vosoughi
AR, Tanideh N. Prevention of arthrofibrosis by
monoclonal antibody against vascular endothelial
growth factor: a novel use of bevacizumab in rabbits.
Orthop Traumatol Surg Res. 2012; 98(7):759-64.
19. Kocaoglu B, Akgun U, Nalbantoglu U, Poyanlı O,
Karahan M. Adhesion reduction after knee surgery
in a rat model by mitomycin C. Knee Surg Sports
Traumatol Arthrosc. 2011; 19(1):94-8.
20. Zhao S, Sun Y, Li X, Wang J, Yan L, Chen H, et al.
Reduction of intraarticular adhesion of knee by local
application of rapamycin in rabbits via inhibition
of fibroblast proliferation and collagen synthesis. J
Orthop Surg Res. 2016; 11(1):45.
21. Johnson R, Zenhausen A, Zollinger H, Mark H, Mcketta
J. Krik-Othmer encyclopedia of chemical technology.
New York: Wiley, Hoboken; 1978. P. 379.
22. Lide DR. CRC handbook of chemistry and physics.
Florida: CRC Press; 2004.
23. Osol A, Remington JP. Remington’s pharmaceutical
sciences. North Carolina: Mack; 1980.
24. American Society of Hospital Pharmacists. American
hospital formulary service drug information.
Maryland: Authority of the Board of Directors of the
American Society of Hospital Pharmacists; 1994.
25. Sunshine I. Handbook of analytical toxicology.
Florida: CRC Press; 1969. P. 77.
26. Aksu B, Inan M, Kanter M, Oz Puyan F, Uzun H,
Durmus-Altun G, et al. The effects of methylene
blue on renal scarring due to pyelonephritis in rats.
Pediatr Nephrol. 2007; 22(7):992-1001.
27. Demirbilek S, Sizanli E, Karadag N, Karaman
A, Bayraktar N, Turkmen E, et al. The effects of
methylene blue on lung injury in septic rats. Eur Surg
Res. 2006; 38(1):35-41.
28. Mentes BB, Akin M, Leventoglu S, Gultekin FA,
Oguz M. Intradermal methylene blue injectionfor
the treatment of intractable idiopathic pruritus
ani:results of 30 cases. Tech Coloproctol. 2004;
8(1):11-4.
29. Miclescu A, Basu S, Wiklund L. Methylene blue added
to a hypertonic–hyperoncotic solution increases
short-term survival in experimental cardiac arrest.
Crit Care Med. 2006; 34(11):2806-13.
30. O’Neil MJ. The merck index an encylopedia of
chemiclas, drugs and biologicals: Cambridge: RSC
Publishing; 2006.
31. Peng B, Zhang Y, Hou S, Wu W, Fu X. Intradiscal
methylene blue injection for the treatment of
chronic discogenic low back pain. Eur Spine J. 2007;
16(1):33-8.
32. Sharr MM, Weller RO, Brice JG. Spinal cord necrosis
after intrathecal injection of methylene blue. J Neurol
Neurosurg Psychiatry. 1978; 41(4):384-6.
33. Sutherland AD, Faragher IG, Frizelle FA. Intradermal
injection of methylene blue for the treatment
of refractory pruritus ani. Colorectal Dis. 2009;
11(3):282-7.
34. Wainwright M, Crossley K. Methylene blue--a
therapeutic dye for all seasons? J Chemother. 2002;
14(5):431-43.
35. Salaris SC, Babbs CF, Voorhees WD 3rd. Methylene
blue as an inhibitor of superoxide generation
by xanthine oxidase. A potential new drug for
the attenuation of ischemia/reperfusion injury.
Biochem Pharmacol. 1991; 42(3):499-506.
36. Noyes FR, DeLucas JL, Torvik PJ. Biomechanics of
anterior cruciate ligament failure: an analysis of
strain-rate sensitivity and mechanisms of failure in
primates. J Bone Joint Surg Am. 1974; 56(2):236-53.
37. Weiler A, Förster C, Hunt P, Falk R, Jung TM,
Unterhauser FN, et al. The influence of locally
applied platelet-derived growth factor-BB on free
tendon graft remodeling after anterior cruciate
ligament reconstruction. Am J Sports Med. 2004;
32(4):881-91.
38. Kalbkhani M, Dehghani S, Najafpour A, Ghorbanzadeh
N. The effect of autogenous platelet rich plasma on
experimentally induced osteoarthritis in rabbit’s
stifles joint: a radiological assessment. J Animal
Poultry Sci. 2013; 2(1):27-38.